CJC-1295 reached phase-2 trials, but experiments were halted due to a myocardial infarction in one of the HIV/AIDS patients treated after the 11th CJC-1295 dose [9, 10]
doi:10.1161/CIRCULATIONAHA.125.074545 Marx N, Husain M, Lehrke M, Verma S, Sattar N
[1] Important safety considerations include: tirzepatide is not recommended during pregnancy or breastfeeding
Routine blood work to monitor thyroid function, lipid panels, hemoglobin A1c, and inflammatory markers allows the physician to adjust the peptide stack as the patients metabolic health improves
The Telehealth Evaluation Process Getting approved is a threestep digital workflow: Online questionnaire : You fill out a health intake form that captures height, weight, medical conditions, and medication list